By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Fluidigm today said it plans to offer more than 5 million shares of its common stock at between $13.50 and $15.50 per share in its planned initial public offering.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.
The American Society of Human Genetics has issued a position statement on genetic testing of children.
The White House seeks to update how biotechnology products are regulated.
Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.
This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.